Date
HS Code
Importer
Exporter
Product Description
Country of Origin
Destination Country
Port of Loading
Port of Discharge
Weight
(unit)
Quantity
(unit)
Value
(unit)
2022-07-07
22 PALLETS 1497 CARTONS PH ARMACEUTICALS AS UNDER CHLO RPROMAZINE HCL TAB 100MG 100 NDC CODE:68462086401 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SU CH AS SCHIZOPHRENIA OR MANIC -DEPRESSION IN ADULTS EZET IMIBE-SIMVA TAB 10/80MG 30 ND C CODE:68462032430 FDA PRODUC T CODE NO.: 61 J D C 15 H. T . S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATIO N IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAIS E GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLE STEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELO NGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY RE DUCING THE AMOUNT OF CHOLESTE ROL MADE BY THE LIVER. FRO VATRIPTAN SUCCINATE TAB 2.5MG 9 NDC CODE:68462069497 FDA P RODUCT CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.92.28 A NDA NO.:204730 THERAPEUTICE U SE: - USE:THE TREATMENT OF M IGRAINE HEADACHES AND FOR SHO RT TERM PREVENTION OF MENSTR UAL MIGRAINE CARVEDILOL TAB 25MG 500 NDC CODE:6846201650 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST TOPIRAMA TE ER CAP (Q) 25MG 30 NDC COD E:68462037230 3004.49.00.20 61 M C B 40 210278 PRAVAST ATIN SOD TAB 80MG 90 NDC CODE :68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 7-987 THERAPEUTICE USE:-HYPO LIPDAEMIC RUFINAMIDE TAB 40 0MG 120 NDC CODE:68462071408 61 M C A 99 3004.90.92.30 2 05075 TO USED WITH OTHER MED ICATIONS TO PREVENT OR CONTRO L SEIZURES (EPILEPSY) ASSOCI ATED WITH LENNOX-GASTAUT SYN DROME (LGS PRAVASTATIN SOD TAB 10MG 500 NDC CODE:6846201 9505 FDA PRODUCT CODE NO.:-6 1 J C A 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.:-77-987 T HERAPEUTICE USE:-HYPOLIPDAEMI C COMMERCIAL & CUSTOM INVOI CE NO. F22387000307 DT. 31.05 .2022 F22387000309 DT. 31.05. 2022 F22387000310 DT. 31.05.2 022 F22387000316 DT. 31.05.20 22 F22387000317 DT. 31.05.202 2 F22387000320 DT. 31.05.2022 F22387000329 DT. 31.05.2022 S/BILL NO: 4007990 DT:02/06 /2022 S/BILL NO: 4007992 DT: 02/06/2022 S/BILL NO: 400799 3 DT:02/06/2022 S/BILL NO: 4007995 DT:02/06/2022 S/BILL NO: 4007996 DT:02/06/2022 S/BILL NO: 4007997 DT:02/06/ 2022 S/BILL NO: 4007999 DT: 02/06/2022 NET WT: 2,701.12 K GS 08 DATA LOGGERS HUMIDITY: 65% SET TEMPERATURE : +18 DEG REES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA.
22 PALLETS 1497 CARTONS PH ARMACEUTICALS AS UNDER CHLO RPROMAZINE HCL TAB 100MG 100 NDC CODE:68462086401 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SU CH AS SCHIZOPHRENIA OR MANIC -DEPRESSION IN ADULTS EZET IMIBE-SIMVA TAB 10/80MG 30 ND C CODE:68462032430 FDA PRODUC T CODE NO.: 61 J D C 15 H. T . S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATIO N IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAIS E GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLE STEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELO NGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY RE DUCING THE AMOUNT OF CHOLESTE ROL MADE BY THE LIVER. FRO VATRIPTAN SUCCINATE TAB 2.5MG 9 NDC CODE:68462069497 FDA P RODUCT CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.92.28 A NDA NO.:204730 THERAPEUTICE U SE: - USE:THE TREATMENT OF M IGRAINE HEADACHES AND FOR SHO RT TERM PREVENTION OF MENSTR UAL MIGRAINE CARVEDILOL TAB 25MG 500 NDC CODE:6846201650 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST TOPIRAMA TE ER CAP (Q) 25MG 30 NDC COD E:68462037230 3004.49.00.20 61 M C B 40 210278 PRAVAST ATIN SOD TAB 80MG 90 NDC CODE :68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 7-987 THERAPEUTICE USE:-HYPO LIPDAEMIC RUFINAMIDE TAB 40 0MG 120 NDC CODE:68462071408 61 M C A 99 3004.90.92.30 2 05075 TO USED WITH OTHER MED ICATIONS TO PREVENT OR CONTRO L SEIZURES (EPILEPSY) ASSOCI ATED WITH LENNOX-GASTAUT SYN DROME (LGS PRAVASTATIN SOD TAB 10MG 500 NDC CODE:6846201 9505 FDA PRODUCT CODE NO.:-6 1 J C A 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.:-77-987 T HERAPEUTICE USE:-HYPOLIPDAEMI C COMMERCIAL & CUSTOM INVOI CE NO. F22387000307 DT. 31.05 .2022 F22387000309 DT. 31.05. 2022 F22387000310 DT. 31.05.2 022 F22387000316 DT. 31.05.20 22 F22387000317 DT. 31.05.202 2 F22387000320 DT. 31.05.2022 F22387000329 DT. 31.05.2022 S/BILL NO: 4007990 DT:02/06 /2022 S/BILL NO: 4007992 DT: 02/06/2022 S/BILL NO: 400799 3 DT:02/06/2022 S/BILL NO: 4007995 DT:02/06/2022 S/BILL NO: 4007996 DT:02/06/2022 S/BILL NO: 4007997 DT:02/06/ 2022 S/BILL NO: 4007999 DT: 02/06/2022 NET WT: 2,701.12 K GS 08 DATA LOGGERS HUMIDITY: 65% SET TEMPERATURE : +18 DEG REES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA.
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4,765
KG
22
PKG
***
USD
2022-07-07
13 PALLETS 422 CARTONS P HARMACEUTICALS AS UNDER FLU OCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059089 F DA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210539 SYNTHETI C CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TREA TMENT OF PSORIASIS OF THE SCA LP NYSTATIN-TRIAM 100K UNIT /0.1% OINT 30GM NDC CODE:6846 2079935 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATME NT OF FUNGAL INFECTIONS OF TH E SKIN, ESPECIALLY YEAST INF ECTIONS. BETAMETHASONE DIP AUG CRM USP 0.05% NDC CODE:68 462029017 FDA PRODUCT CODE NO .: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO.:78-93 0 THERAPEUTICE USE: DERMALOG IC USE MOMETASONE FURO TOP SOL 0.1% 60ML NDC CODE:684620 38502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 300 4.90.92.45 ANDA NO.:090506 T HERAPEUTICE USE: MOMETASONE F UROATE TOPICAL SOLUTION (LOTI ON) IS A CORTICOSTEROID INDI CATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MAN IFESTATIONS OF CORTICOSTEROID -RESPONSIVE DERMATOSES IN PAT IENTS #12 YEARS OF AGE. C OMMERCIAL & CUSTOM INVOICE NO. F22335000804 DT. 27.05.2022 S/BILL NO: 1738232 DT:28/05/2 022 NET WT: 1005.84 KGS 13 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2.
13 PALLETS 422 CARTONS P HARMACEUTICALS AS UNDER FLU OCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059089 F DA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210539 SYNTHETI C CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TREA TMENT OF PSORIASIS OF THE SCA LP NYSTATIN-TRIAM 100K UNIT /0.1% OINT 30GM NDC CODE:6846 2079935 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATME NT OF FUNGAL INFECTIONS OF TH E SKIN, ESPECIALLY YEAST INF ECTIONS. BETAMETHASONE DIP AUG CRM USP 0.05% NDC CODE:68 462029017 FDA PRODUCT CODE NO .: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO.:78-93 0 THERAPEUTICE USE: DERMALOG IC USE MOMETASONE FURO TOP SOL 0.1% 60ML NDC CODE:684620 38502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 300 4.90.92.45 ANDA NO.:090506 T HERAPEUTICE USE: MOMETASONE F UROATE TOPICAL SOLUTION (LOTI ON) IS A CORTICOSTEROID INDI CATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MAN IFESTATIONS OF CORTICOSTEROID -RESPONSIVE DERMATOSES IN PAT IENTS #12 YEARS OF AGE. C OMMERCIAL & CUSTOM INVOICE NO. F22335000804 DT. 27.05.2022 S/BILL NO: 1738232 DT:28/05/2 022 NET WT: 1005.84 KGS 13 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2.
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1,999
KG
13
PKG
***
USD
2022-07-07
"7 PALLETS 643 CARTON S PHARMACEUTICALS AS UNDER ATOVAQUONE ORAL SUSP 750MG/ 5ML 210ML NDC CODE:6846204212 1 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90 .92.90 ANDA NO.: 209685 USED TO PREVENT OR TREAT A SERIOU S LUNG INFECTION CALLED PNEUM OCYSTIS PNEUMONIA (PCP). THIS MEDICATION HELPS TO STOP IN FECTION SYMPTOMS SUCH AS FEVE R, COUGH, TIREDNESS, AND SHOR TNESS OF BREATH. COMMERCIA L & CUSTOM INVOICE NO. F22335 000936 DT. 31.05.2022 NET WT. 2,361.10 KGS 07 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND S/BILL NO: 1924315 DT: 06-JUN -22
"
"7 PALLETS 643 CARTON S PHARMACEUTICALS AS UNDER ATOVAQUONE ORAL SUSP 750MG/ 5ML 210ML NDC CODE:6846204212 1 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90 .92.90 ANDA NO.: 209685 USED TO PREVENT OR TREAT A SERIOU S LUNG INFECTION CALLED PNEUM OCYSTIS PNEUMONIA (PCP). THIS MEDICATION HELPS TO STOP IN FECTION SYMPTOMS SUCH AS FEVE R, COUGH, TIREDNESS, AND SHOR TNESS OF BREATH. COMMERCIA L & CUSTOM INVOICE NO. F22335 000936 DT. 31.05.2022 NET WT. 2,361.10 KGS 07 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND S/BILL NO: 1924315 DT: 06-JUN -22
"
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2,685
KG
7
PKG
***
USD
2022-07-07
7 PALLETS 106 CARTONS P HARMACEUTICALS AS UNDER NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031435 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031465 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS. MO METASONE FURO SOLN 0.1% 60ML NDC CODE:68462038502 FDA PROD UCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92.45 AND A NO.:090506 THERAPEUTICE USE : MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORT ICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOSES IN PATIENTS #12 YEA RS OF AGE. COMMERCIAL & CUS TOM INVOICE NO. F22335000930 DT. 31.05.2022 F22335000931 D T. 31.05.2022 NET WT. 455.04 07 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
7 PALLETS 106 CARTONS P HARMACEUTICALS AS UNDER NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031435 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031465 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS. MO METASONE FURO SOLN 0.1% 60ML NDC CODE:68462038502 FDA PROD UCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92.45 AND A NO.:090506 THERAPEUTICE USE : MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORT ICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOSES IN PATIENTS #12 YEA RS OF AGE. COMMERCIAL & CUS TOM INVOICE NO. F22335000930 DT. 31.05.2022 F22335000931 D T. 31.05.2022 NET WT. 455.04 07 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
910
KG
7
PKG
***
USD
2022-07-07
"7 PALLETS 106 CARTONS P HARMACEUTICALS AS UNDER NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031435 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031465 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS. MO METASONE FURO SOLN 0.1% 60ML NDC CODE:68462038502 FDA PROD UCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92.45 AND A NO.:090506 THERAPEUTICE USE : MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORT ICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOSES IN PATIENTS #12 YEA RS OF AGE. COMMERCIAL & CUS TOM INVOICE NO. F22335000930 DT. 31.05.2022 F22335000931 D T. 31.05.2022 NET WT. 455.04 07 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
"
"7 PALLETS 106 CARTONS P HARMACEUTICALS AS UNDER NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031435 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031465 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS. MO METASONE FURO SOLN 0.1% 60ML NDC CODE:68462038502 FDA PROD UCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92.45 AND A NO.:090506 THERAPEUTICE USE : MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORT ICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOSES IN PATIENTS #12 YEA RS OF AGE. COMMERCIAL & CUS TOM INVOICE NO. F22335000930 DT. 31.05.2022 F22335000931 D T. 31.05.2022 NET WT. 455.04 07 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
"
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
910
KG
7
PKG
***
USD
2022-07-07
"22 PALLETS 1497 CARTONS PH ARMACEUTICALS AS UNDER CHLO RPROMAZINE HCL TAB 100MG 100 NDC CODE:68462086401 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SU CH AS SCHIZOPHRENIA OR MANIC -DEPRESSION IN ADULTS EZET IMIBE-SIMVA TAB 10/80MG 30 ND C CODE:68462032430 FDA PRODUC T CODE NO.: 61 J D C 15 H. T . S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATIO N IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAIS E GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLE STEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELO NGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY RE DUCING THE AMOUNT OF CHOLESTE ROL MADE BY THE LIVER. FRO VATRIPTAN SUCCINATE TAB 2.5MG 9 NDC CODE:68462069497 FDA P RODUCT CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.92.28 A NDA NO.:204730 THERAPEUTICE U SE: - USE:THE TREATMENT OF M IGRAINE HEADACHES AND FOR SHO RT TERM PREVENTION OF MENSTR UAL MIGRAINE CARVEDILOL TAB 25MG 500 NDC CODE:6846201650 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST TOPIRAMA TE ER CAP (Q) 25MG 30 NDC COD E:68462037230 3004.49.00.20 61 M C B 40 210278 PRAVAST ATIN SOD TAB 80MG 90 NDC CODE :68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 7-987 THERAPEUTICE USE:-HYPO LIPDAEMIC RUFINAMIDE TAB 40 0MG 120 NDC CODE:68462071408 61 M C A 99 3004.90.92.30 2 05075 TO USED WITH OTHER MED ICATIONS TO PREVENT OR CONTRO L SEIZURES (EPILEPSY) ASSOCI ATED WITH LENNOX-GASTAUT SYN DROME (LGS PRAVASTATIN SOD TAB 10MG 500 NDC CODE:6846201 9505 FDA PRODUCT CODE NO.:-6 1 J C A 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.:-77-987 T HERAPEUTICE USE:-HYPOLIPDAEMI C COMMERCIAL & CUSTOM INVOI CE NO. F22387000307 DT. 31.05 .2022 F22387000309 DT. 31.05. 2022 F22387000310 DT. 31.05.2 022 F22387000316 DT. 31.05.20 22 F22387000317 DT. 31.05.202 2 F22387000320 DT. 31.05.2022 F22387000329 DT. 31.05.2022 S/BILL NO: 4007990 DT:02/06 /2022 S/BILL NO: 4007992 DT: 02/06/2022 S/BILL NO: 400799 3 DT:02/06/2022 S/BILL NO: 4007995 DT:02/06/2022 S/BILL NO: 4007996 DT:02/06/2022 S/BILL NO: 4007997 DT:02/06/ 2022 S/BILL NO: 4007999 DT: 02/06/2022 NET WT: 2,701.12 K GS 08 DATA LOGGERS HUMIDITY: 65% SET TEMPERATURE : +18 DEG REES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA.
"
"22 PALLETS 1497 CARTONS PH ARMACEUTICALS AS UNDER CHLO RPROMAZINE HCL TAB 100MG 100 NDC CODE:68462086401 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SU CH AS SCHIZOPHRENIA OR MANIC -DEPRESSION IN ADULTS EZET IMIBE-SIMVA TAB 10/80MG 30 ND C CODE:68462032430 FDA PRODUC T CODE NO.: 61 J D C 15 H. T . S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATIO N IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAIS E GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLE STEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELO NGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY RE DUCING THE AMOUNT OF CHOLESTE ROL MADE BY THE LIVER. FRO VATRIPTAN SUCCINATE TAB 2.5MG 9 NDC CODE:68462069497 FDA P RODUCT CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.92.28 A NDA NO.:204730 THERAPEUTICE U SE: - USE:THE TREATMENT OF M IGRAINE HEADACHES AND FOR SHO RT TERM PREVENTION OF MENSTR UAL MIGRAINE CARVEDILOL TAB 25MG 500 NDC CODE:6846201650 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST TOPIRAMA TE ER CAP (Q) 25MG 30 NDC COD E:68462037230 3004.49.00.20 61 M C B 40 210278 PRAVAST ATIN SOD TAB 80MG 90 NDC CODE :68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 7-987 THERAPEUTICE USE:-HYPO LIPDAEMIC RUFINAMIDE TAB 40 0MG 120 NDC CODE:68462071408 61 M C A 99 3004.90.92.30 2 05075 TO USED WITH OTHER MED ICATIONS TO PREVENT OR CONTRO L SEIZURES (EPILEPSY) ASSOCI ATED WITH LENNOX-GASTAUT SYN DROME (LGS PRAVASTATIN SOD TAB 10MG 500 NDC CODE:6846201 9505 FDA PRODUCT CODE NO.:-6 1 J C A 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.:-77-987 T HERAPEUTICE USE:-HYPOLIPDAEMI C COMMERCIAL & CUSTOM INVOI CE NO. F22387000307 DT. 31.05 .2022 F22387000309 DT. 31.05. 2022 F22387000310 DT. 31.05.2 022 F22387000316 DT. 31.05.20 22 F22387000317 DT. 31.05.202 2 F22387000320 DT. 31.05.2022 F22387000329 DT. 31.05.2022 S/BILL NO: 4007990 DT:02/06 /2022 S/BILL NO: 4007992 DT: 02/06/2022 S/BILL NO: 400799 3 DT:02/06/2022 S/BILL NO: 4007995 DT:02/06/2022 S/BILL NO: 4007996 DT:02/06/2022 S/BILL NO: 4007997 DT:02/06/ 2022 S/BILL NO: 4007999 DT: 02/06/2022 NET WT: 2,701.12 K GS 08 DATA LOGGERS HUMIDITY: 65% SET TEMPERATURE : +18 DEG REES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA.
"
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4,765
KG
22
PKG
***
USD
2022-07-07
7 PALLETS 643 CARTON S PHARMACEUTICALS AS UNDER ATOVAQUONE ORAL SUSP 750MG/ 5ML 210ML NDC CODE:6846204212 1 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90 .92.90 ANDA NO.: 209685 USED TO PREVENT OR TREAT A SERIOU S LUNG INFECTION CALLED PNEUM OCYSTIS PNEUMONIA (PCP). THIS MEDICATION HELPS TO STOP IN FECTION SYMPTOMS SUCH AS FEVE R, COUGH, TIREDNESS, AND SHOR TNESS OF BREATH. COMMERCIA L & CUSTOM INVOICE NO. F22335 000936 DT. 31.05.2022 NET WT. 2,361.10 KGS 07 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND S/BILL NO: 1924315 DT: 06-JUN -22
7 PALLETS 643 CARTON S PHARMACEUTICALS AS UNDER ATOVAQUONE ORAL SUSP 750MG/ 5ML 210ML NDC CODE:6846204212 1 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90 .92.90 ANDA NO.: 209685 USED TO PREVENT OR TREAT A SERIOU S LUNG INFECTION CALLED PNEUM OCYSTIS PNEUMONIA (PCP). THIS MEDICATION HELPS TO STOP IN FECTION SYMPTOMS SUCH AS FEVE R, COUGH, TIREDNESS, AND SHOR TNESS OF BREATH. COMMERCIA L & CUSTOM INVOICE NO. F22335 000936 DT. 31.05.2022 NET WT. 2,361.10 KGS 07 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND S/BILL NO: 1924315 DT: 06-JUN -22
52330, SALALAH
"4601, NEW YORK/NEWARK AREA, NEWARK, NJ"
2,685
KG
7
PKG
***
USD
2022-07-07
"13 PALLETS 422 CARTONS P HARMACEUTICALS AS UNDER FLU OCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059089 F DA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210539 SYNTHETI C CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TREA TMENT OF PSORIASIS OF THE SCA LP NYSTATIN-TRIAM 100K UNIT /0.1% OINT 30GM NDC CODE:6846 2079935 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATME NT OF FUNGAL INFECTIONS OF TH E SKIN, ESPECIALLY YEAST INF ECTIONS. BETAMETHASONE DIP AUG CRM USP 0.05% NDC CODE:68 462029017 FDA PRODUCT CODE NO .: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO.:78-93 0 THERAPEUTICE USE: DERMALOG IC USE MOMETASONE FURO TOP SOL 0.1% 60ML NDC CODE:684620 38502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 300 4.90.92.45 ANDA NO.:090506 T HERAPEUTICE USE: MOMETASONE F UROATE TOPICAL SOLUTION (LOTI ON) IS A CORTICOSTEROID INDI CATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MAN IFESTATIONS OF CORTICOSTEROID -RESPONSIVE DERMATOSES IN PAT IENTS #12 YEARS OF AGE. C OMMERCIAL & CUSTOM INVOICE NO. F22335000804 DT. 27.05.2022 S/BILL NO: 1738232 DT:28/05/2 022 NET WT: 1005.84 KGS 13 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2.
"
"13 PALLETS 422 CARTONS P HARMACEUTICALS AS UNDER FLU OCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059089 F DA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210539 SYNTHETI C CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TREA TMENT OF PSORIASIS OF THE SCA LP NYSTATIN-TRIAM 100K UNIT /0.1% OINT 30GM NDC CODE:6846 2079935 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATME NT OF FUNGAL INFECTIONS OF TH E SKIN, ESPECIALLY YEAST INF ECTIONS. BETAMETHASONE DIP AUG CRM USP 0.05% NDC CODE:68 462029017 FDA PRODUCT CODE NO .: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO.:78-93 0 THERAPEUTICE USE: DERMALOG IC USE MOMETASONE FURO TOP SOL 0.1% 60ML NDC CODE:684620 38502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 300 4.90.92.45 ANDA NO.:090506 T HERAPEUTICE USE: MOMETASONE F UROATE TOPICAL SOLUTION (LOTI ON) IS A CORTICOSTEROID INDI CATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MAN IFESTATIONS OF CORTICOSTEROID -RESPONSIVE DERMATOSES IN PAT IENTS #12 YEARS OF AGE. C OMMERCIAL & CUSTOM INVOICE NO. F22335000804 DT. 27.05.2022 S/BILL NO: 1738232 DT:28/05/2 022 NET WT: 1005.84 KGS 13 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2.
"
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1,999
KG
13
PKG
***
USD
2022-07-07
7 PALLETS 106 CARTONS P HARMACEUTICALS AS UNDER NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031435 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031465 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS. MO METASONE FURO SOLN 0.1% 60ML NDC CODE:68462038502 FDA PROD UCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92.45 AND A NO.:090506 THERAPEUTICE USE : MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORT ICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOSES IN PATIENTS #12 YEA RS OF AGE. COMMERCIAL & CUS TOM INVOICE NO. F22335000930 DT. 31.05.2022 F22335000931 D T. 31.05.2022 NET WT. 455.04 07 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
7 PALLETS 106 CARTONS P HARMACEUTICALS AS UNDER NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031435 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031465 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS. MO METASONE FURO SOLN 0.1% 60ML NDC CODE:68462038502 FDA PROD UCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92.45 AND A NO.:090506 THERAPEUTICE USE : MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORT ICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOSES IN PATIENTS #12 YEA RS OF AGE. COMMERCIAL & CUS TOM INVOICE NO. F22335000930 DT. 31.05.2022 F22335000931 D T. 31.05.2022 NET WT. 455.04 07 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
52330, SALALAH
"4601, NEW YORK/NEWARK AREA, NEWARK, NJ"
910
KG
7
PKG
***
USD
2022-07-07
13 PALLETS 422 CARTONS P HARMACEUTICALS AS UNDER FLU OCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059089 F DA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210539 SYNTHETI C CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TREA TMENT OF PSORIASIS OF THE SCA LP NYSTATIN-TRIAM 100K UNIT /0.1% OINT 30GM NDC CODE:6846 2079935 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATME NT OF FUNGAL INFECTIONS OF TH E SKIN, ESPECIALLY YEAST INF ECTIONS. BETAMETHASONE DIP AUG CRM USP 0.05% NDC CODE:68 462029017 FDA PRODUCT CODE NO .: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO.:78-93 0 THERAPEUTICE USE: DERMALOG IC USE MOMETASONE FURO TOP SOL 0.1% 60ML NDC CODE:684620 38502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 300 4.90.92.45 ANDA NO.:090506 T HERAPEUTICE USE: MOMETASONE F UROATE TOPICAL SOLUTION (LOTI ON) IS A CORTICOSTEROID INDI CATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MAN IFESTATIONS OF CORTICOSTEROID -RESPONSIVE DERMATOSES IN PAT IENTS #12 YEARS OF AGE. C OMMERCIAL & CUSTOM INVOICE NO. F22335000804 DT. 27.05.2022 S/BILL NO: 1738232 DT:28/05/2 022 NET WT: 1005.84 KGS 13 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2.
13 PALLETS 422 CARTONS P HARMACEUTICALS AS UNDER FLU OCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059089 F DA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210539 SYNTHETI C CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TREA TMENT OF PSORIASIS OF THE SCA LP NYSTATIN-TRIAM 100K UNIT /0.1% OINT 30GM NDC CODE:6846 2079935 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATME NT OF FUNGAL INFECTIONS OF TH E SKIN, ESPECIALLY YEAST INF ECTIONS. BETAMETHASONE DIP AUG CRM USP 0.05% NDC CODE:68 462029017 FDA PRODUCT CODE NO .: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO.:78-93 0 THERAPEUTICE USE: DERMALOG IC USE MOMETASONE FURO TOP SOL 0.1% 60ML NDC CODE:684620 38502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 300 4.90.92.45 ANDA NO.:090506 T HERAPEUTICE USE: MOMETASONE F UROATE TOPICAL SOLUTION (LOTI ON) IS A CORTICOSTEROID INDI CATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MAN IFESTATIONS OF CORTICOSTEROID -RESPONSIVE DERMATOSES IN PAT IENTS #12 YEARS OF AGE. C OMMERCIAL & CUSTOM INVOICE NO. F22335000804 DT. 27.05.2022 S/BILL NO: 1738232 DT:28/05/2 022 NET WT: 1005.84 KGS 13 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2.
52330, SALALAH
"4601, NEW YORK/NEWARK AREA, NEWARK, NJ"
1,999
KG
13
PKG
***
USD